Composite Interceptive Med Science
10
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.
Role: lead
Herbal Tea in the Treatment of Type 2 Diabetes Mellitus
Role: lead
Tulsi Consumption and Its Effects on Cognition, Stress and Anxiety
Role: lead
Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver Disease
Role: lead
Management of Frailty in Older Adults With Turmeric and Tulsi Supplements
Role: lead
Influenza Management With Polyherbal Formulation
Role: lead
Role of Herbs in the Management of Asthma
Role: lead
Effect of Polyherbal Compound for Control of Blood Sugar in Impaired Glucose Tolerance and Diabetes
Role: lead
Effect of Polyherbal Formulation in Chronic Inactive Carriers of Hepatitis B Virus
Role: lead
Control of Blood Glucose Fluctuation With Usage of Polyherbal
Role: lead
All 10 trials loaded